BRIACELL THERAP (BCTX)
(Real Time Quote from BATS)
$12.91 USD
-0.43 (-3.22%)
Updated Oct 29, 2025 12:18 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BCTX 12.91 -0.43(-3.22%)
Will BCTX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for BCTX based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for BCTX
Zacks.com featured highlights include Groupon, BriaCell Therapeutics and InnovAge Holding
Top 3 Earnings Acceleration Buys for November
BCTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About BRIACELL THERAP (BCTX) Rating Upgrade to Buy
BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?
Other News for BCTX
BCTX forms Bollinger Band Squeeze on October 28
Is BCTX set to breakout? Bollinger Band Squeeze shows up after dropping 2.68%
BCTX forms MACD Bullish Signal Line Cross on October 24
Is BCTX positioned for a breakout? Crossed Above 20 Day Moving Average shows up after surging 9.05%
Slingshot Bullish appears for BCTX after 5.64% move